Needelman Asset Management’s Bristol-Myers Squibb BMY Stock Holding History

Needelman Asset Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-14,275	Closed	-$790K	–	6
2018 Q2	$790K	Buy	14,275 +225	+2%	+$12.2K	1.72%	32
2018 Q1	$889K	Sell	14,050 -100	-0.7%	-$6.43K	1.92%	31
2017 Q4	$867K	Sell	14,150 -50	-0.4%	-$3.13K	2.17%	30
2017 Q3	$905K	Sell	14,200 -500	-3%	-$29.2K	2.22%	24
2017 Q2	$819K	Hold	14,700	–	–	2.11%	31
2017 Q1	$799K	Sell	14,700 -100	-0.7%	-$5.49K	2.14%	28
2016 Q4	$865K	Sell	14,800 -30	-0.2%	-$1.64K	2.4%	25
2016 Q3	$800K	Hold	14,830	–	–	2.4%	26
2016 Q2	$1.09M	Sell	14,830 -50	-0.3%	-$3.53K	3.11%	11
2016 Q1	$951K	Buy	14,880 +800	+6%	+$50.5K	2.78%	18
2015 Q4	$969K	Hold	14,080	–	–	2.94%	14
2015 Q3	$834K	Hold	14,080	–	–	2.74%	16
2015 Q2	$937K	Sell	14,080 -400	-3%	-$26.4K	2.96%	14
2015 Q1	$934K	Sell	14,480 -175	-1%	-$11K	2.83%	16
2014 Q4	$865K	Hold	14,655	–	–	2.65%	19
2014 Q3	$750K	Hold	14,655	–	–	2.4%	25
2014 Q2	$711K	Hold	14,655	–	–	2.25%	28
2014 Q1	$761K	Sell	14,655 -575	-4%	-$30.6K	2.47%	25
2013 Q4	$809K	Sell	15,230 -200	-1%	-$10.2K	2.67%	23
2013 Q3	$714K	Hold	15,430	–	–	2.56%	24
2013 Q2	$690K	Buy	+15,430	New	+$670K	2.52%	23

Other funds holding BMY

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Needelman Asset Management's BMY Position: Q3 2018 in Review

Needelman Asset Management sold out of Bristol-Myers Squibb (BMY) in Q3 2018, closing a stake of 14,275 shares — an estimated $790K sold.

Needelman Asset Management first reported a position in BMY in Q2 2013 and held it in 21 quarters. The position peaked at $1.09M in Q2 2016. 1,730 funds tracked by Wall St. Rank hold BMY as of Q3 2018.

Needelman Asset Management reported no remaining Bristol-Myers Squibb position as of Q3 2018 after selling out during the quarter.
Needelman Asset Management sold 14,275 Bristol-Myers Squibb shares in Q3 2018, an estimated $790K.
Needelman Asset Management first reported a position in Bristol-Myers Squibb in Q2 2013 and held it in 21 quarters.
Needelman Asset Management's Bristol-Myers Squibb position peaked at $1.09M in Q2 2016.
1,730 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2018.

Based on Needelman Asset Management's 13F filing for Q3 2018.